Clindamycin-Resistant Group B Streptococcus and Failure of Intrapartum Prophylaxis to Prevent Early-Onset Disease

Anne J. Blaschke, Laurie S. Pulver, E. Kent Korgenski, Lucy A. Savitz, Judy A. Daly, Carrie L. Byington

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Guidelines recommend intrapartum antibiotic prophylaxis (IAP) for parturient women who have a screen positive for group B Streptococcus (GBS). Clindamycin should be used for IAP only if the maternal GBS isolate is susceptible. We report a case of clindamycin-resistant GBS disease in a newborn infant whose mother received clindamycin IAP, and we review clindamycin susceptibility testing.

Original languageEnglish (US)
Pages (from-to)501-503
Number of pages3
JournalJournal of Pediatrics
Volume156
Issue number3
DOIs
StatePublished - Mar 2010

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Clindamycin-Resistant Group B Streptococcus and Failure of Intrapartum Prophylaxis to Prevent Early-Onset Disease'. Together they form a unique fingerprint.

Cite this